SAN FRANCISCO — Arysta LifeScience North America has secured exclusive domestic marketing rights for fluoxastrobin, a strobilurin fungicide in development for disease control.

Fluoxastrobin is being tested in university trials. The company anticipates registrations sometime in late 2005 to early 2006. The company expects to launch several new fungicides into the turf and ornamental markets based on the new product.

"We're excited about this opportunity to establish Arysta LifeScience as a long-term player in the turf and ornamental marketplace with our channel partners and end users," said Bill Liles, turf and ornamental business manager.

Related stories:

"Arvesta Corp changes name and plans headquarters move," LM Week in Review, August 10, 2005.

"Arvesta names Bill Liles business manager for its Turf & Ornamental business," LM Week in Review, December 22, 2004.